516 related articles for article (PubMed ID: 35057530)
1. Gut Microbiome and Organ Fibrosis.
Costa CFFA; Sampaio-Maia B; Araujo R; Nascimento DS; Ferreira-Gomes J; Pestana M; Azevedo MJ; Alencastre IS
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057530
[TBL] [Abstract][Full Text] [Related]
2. Dysbiotic microbiota interactions in Crohn's disease.
Caparrós E; Wiest R; Scharl M; Rogler G; Gutiérrez Casbas A; Yilmaz B; Wawrzyniak M; Francés R
Gut Microbes; 2021; 13(1):1949096. PubMed ID: 34313550
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
4. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
5. Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
Carter JK; Bhattacharya D; Borgerding JN; Fiel MI; Faith JJ; Friedman SL
PLoS One; 2021; 16(1):e0244763. PubMed ID: 33395434
[TBL] [Abstract][Full Text] [Related]
6. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
7. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
Maccioni L; Leclercq IA; Schnabl B; Stärkel P
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
[TBL] [Abstract][Full Text] [Related]
8. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
Acharya C; Sahingur SE; Bajaj JS
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
[TBL] [Abstract][Full Text] [Related]
9. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722100
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis.
Maslennikov R; Poluektova E; Zolnikova O; Sedova A; Kurbatova A; Shulpekova Y; Dzhakhaya N; Kardasheva S; Nadinskaia M; Bueverova E; Nechaev V; Karchevskaya A; Ivashkin V
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003692
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
12. Microbiome and Gut Dysbiosis.
Belizário JE; Faintuch J
Exp Suppl; 2018; 109():459-476. PubMed ID: 30535609
[TBL] [Abstract][Full Text] [Related]
13. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
14. Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development.
Ronan V; Yeasin R; Claud EC
Gastroenterology; 2021 Jan; 160(2):495-506. PubMed ID: 33307032
[TBL] [Abstract][Full Text] [Related]
15. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease.
Chi M; Ma K; Wang J; Ding Z; Li Y; Zhu S; Liang X; Zhang Q; Song L; Liu C
J Immunol Res; 2021; 2021():5516035. PubMed ID: 34095319
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
17. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
Li J; Yang X; Zhou X; Cai J
Antioxid Redox Signal; 2021 Apr; 34(10):811-830. PubMed ID: 32316741
[No Abstract] [Full Text] [Related]
18. The impact of gut microbiota on kidney function and pathogenesis.
Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis and liver diseases (Review).
Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34328191
[TBL] [Abstract][Full Text] [Related]
20. Gut-Lung Dysbiosis Accompanied by Diabetes Mellitus Leads to Pulmonary Fibrotic Change through the NF-κB Signaling Pathway.
Wang G; Hu YX; He MY; Xie YH; Su W; Long D; Zhao R; Wang J; Dai C; Li H; Si ZP; Cheng X; Li RM; Li Z; Yang X
Am J Pathol; 2021 May; 191(5):838-856. PubMed ID: 33705752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
